- World rank, all time
- #28,513 of 42,892
- Rank in United States
- #6,110 of 8,685
- Research works
- 197 ▼ 34% vs 2013–17
- Citations
- 7.5k 38.3 per fractional work
- Top-10% rate
- 15.9% record average 16.5%
- Open access
- 17% world 28%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Veterinary, 31.4×. Every wedge is a field page.
- Veterinary 31.4×
- Pharmacology, Toxicology and Pharmaceutics 15.2×
- Chemistry 10.3×
- Immunology and Microbiology 5.3×
- Nursing 2.9×
- Neuroscience 2.6×
- Chemical Engineering 2.4×
- Medicine 2.2×
- Business, Management and Accounting 2.0×
- Biochemistry, Genetics and Molecular Biology 1.2×
- Materials Science 0.5×
- Agricultural and Biological Sciences 0.5×
- Computer Science 0.2×
- Engineering 0.0×
Who are the top researchers at Enzon Pharmaceuticals (United States)?
Ranked on the composite score, Lee M. Greenberger, Aby Buchbinder and Yixian Zhang lead among researchers whose main affiliation is Enzon Pharmaceuticals (United States).
- 1 Lee M. Greenberger United States · #132,566 worldwide 146 citations · 24 works
- 2 Aby Buchbinder United States · #757,994 worldwide 52 citations · 15 works
- 3 Yixian Zhang United States · #1,232,953 worldwide 37 citations · 22 works
Which keywords describe research at Enzon Pharmaceuticals (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Chemotherapy, Glycosylation, Cancer Therapy, Monoclonal Antibodies, Therapeutic Antibodies, Drug Discovery, Genomic Stability and Gene Therapy.
- Therapeutic Targets
- Mucins
- Chemotherapy-Induced Peripheral Neuropathy
- Gene Silencing
- RNA Interference
- Genomic Profiling
- Peptide Synthesis
- Protein-Protein Interactions
- Fc Receptors
- Drug Delivery
- DNA
- Anticancer Drugs
- Hemoglobin
- Targeted Therapy
- Genetic Variants
- Gene Therapy
- Drug Discovery
- Monoclonal Antibodies
- Cancer
- Glycosylation
- Chemotherapy
- Nanoparticles
- Cancer Therapy
- Therapeutic Antibodies
- Genomic Stability
- Immunotherapy
- Clinical Trials
- Biomedical Applications
- Scavenger Receptor
- Neurotoxicity
- Topoisomerases
- Antibody Engineering
- Tumor Targeting
- Foldamers
- Apoptosis
- Monoclonal Antibody
- Immune System
- siRNA Delivery
- Glycans
- Taxanes
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Chemotherapy14▲ 9.8×9 topics
- Glycosylation12▲ 28×3 topics
- Nanoparticles11▲ 4.1×10 topics
- Cancer10▲ 3.7×14 topics
- Cancer Therapy10▲ 7.7×7 topics
- Monoclonal Antibodies9▲ 32×3 topics
- Therapeutic Antibodies9▲ 35×2 topics
- Drug Discovery9▲ 11×5 topics
- Genomic Stability8▲ 46×2 topics
- Gene Therapy8▲ 16×5 topics
- Immunotherapy8▲ 6.3×9 topics
- Genetic Variants8▲ 19×4 topics
- Clinical Trials8▲ 6.4×7 topics
- Targeted Therapy8▲ 18×5 topics
- Biomedical Applications7▲ 3.5×9 topics
- Hemoglobin7▲ 128×1 topic
- Scavenger Receptor7▲ 128×1 topic
- Anticancer Drugs7▲ 79×2 topics
- Neurotoxicity6▲ 18×4 topics
- DNA6▲ 103×1 topic
- Topoisomerases6▲ 103×1 topic
- Drug Delivery6▲ 6.6×5 topics
- Antibody Engineering6▲ 31×1 topic
- Fc Receptors6▲ 31×1 topic
- Tumor Targeting6▲ 22×3 topics
- Protein-Protein Interactions6▲ 27×3 topics
- Foldamers5▲ 34×1 topic
- Peptide Synthesis5▲ 34×1 topic
- Apoptosis5▲ 6.8×7 topics
- Genomic Profiling5▲ 26×2 topics
- Monoclonal Antibody5▲ 36×2 topics
- RNA Interference5▲ 23×2 topics
- Immune System5▲ 7.7×3 topics
- Gene Silencing5▲ 20×1 topic
- siRNA Delivery5▲ 32×1 topic
- Chemotherapy-Induced Peripheral Neuropathy4▲ 45×1 topic
- Glycans4▲ 27×1 topic
- Mucins4▲ 27×1 topic
- Taxanes4▲ 45×1 topic
- Therapeutic Targets4▲ 8.8×6 topics
Which research topics does Enzon Pharmaceuticals (United States) publish most on?
By volume in 2022–2025: Analytical Methods in Pharmaceuticals, Supply Chain Resilience and Risk Management, Analytical Chemistry and Chromatography and Medical Device Sterilization and Disinfection.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Analytical Methods in Pharmaceuticals Analytical Chemistry 1 works
- 2 Supply Chain Resilience and Risk Management Strategy and Management 0 works
- 3 Analytical Chemistry and Chromatography Spectroscopy 0 works
- 4 Medical Device Sterilization and Disinfection Microbiology 0 works
- 5 Pain Mechanisms and Treatments Physiology 0 works
- 6 Antibiotics Pharmacokinetics and Efficacy Pharmacology 0 works
- 7 Animal testing and alternatives Small Animals 0 works
- 8 Pharmaceutical studies and practices Pediatrics, Perinatology and Child Health 0 works
- 9 Pain Management and Placebo Effect Cognitive Neuroscience 0 works
- 10 Phytochemistry and biological activities of Ficus species Plant Science 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Enzon Pharmaceuticals (United States)'s research output changed?
Output in 2018–2022 was 34% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Piscataway
- Environmental and Occupational Health Sciences Institute
- Institute of Electrical and Electronics Engineers
- Center for Discrete Mathematics and Theoretical Computer Science
- American Standard (United States)
- Diamond Materials (United States)
- Gorgias Press (United States)
- Structured Materials Industries (United States)
- African Studies Association
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.